Related references
Note: Only part of the references are listed.MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction
Yanfei Yang et al.
CIRCULATION RESEARCH (2015)
Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach
Le Kang et al.
STATISTICS IN MEDICINE (2015)
Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction
Fabiola Olivieri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Circulating miR-208b and miR-34a Are Associated with Left Ventricular Remodeling after Acute Myocardial Infarction
Pin Lv et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
MicroRNA-378 controls classical brown fat expansion to counteract obesity
Dongning Pan et al.
NATURE COMMUNICATIONS (2014)
Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction
Olof Gidlof et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations
Judith A. Finegold et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
被撤回的出版物: A Cardiac-enriched MicroRNA, miR-378, Blocks Cardiac Hypertrophy by Targeting Ras Signaling(Retracted article. See vol. 292, pg. 5123, 2017)
Raghu S. Nagalingam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MicroRNA-34a regulates cardiac ageing and function
Reinier A. Boon et al.
NATURE (2013)
Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction
Ingo Eitel et al.
AMERICAN HEART JOURNAL (2012)
Interpreting Incremental Value of Markers Added to Risk Prediction Models
Michael J. Pencina et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Circulating Troponin As Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention
David M. Leistner et al.
CLINICAL CHEMISTRY (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Anna Zampetaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction
Benjamin Meder et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Cohort Profile: The Study of Health in Pomerania
Henry Voelzke et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome
Christian Widera et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Pervasive roles of microRNAs in cardiovascular biology
Eric M. Small et al.
NATURE (2011)
Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial
Robert L. Ohsfeldt et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
A simple risk score using routine data for predicting cardiovascular disease in primary care
Parinya Chamnan et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2010)
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism
Han Lu et al.
CARDIOVASCULAR RESEARCH (2010)
Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project
Stefan Blankenberg et al.
CIRCULATION (2010)
Circulating MicroRNAs in Patients With Coronary Artery Disease
Stephan Fichtlscherer et al.
CIRCULATION RESEARCH (2010)
Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease
Shashi K. Gupta et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease
Maarten F. Corsten et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction
Taichi Adachi et al.
CLINICAL CHEMISTRY (2010)
Statistical methods for assessment of added usefulness of new biomarkers
Michael J. Pencina et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
James A. de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
Jonathan B. Johnnidis et al.
NATURE (2008)
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
Bjorn Zethelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
JF Chen et al.
NATURE GENETICS (2006)
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
C Kistorp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Cardiovascular risk factors in primary care:: methods and baseline prevalence rates -: the DETECT program
HU Wittchen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
